6 Nov 2021
Britain on Thursday (November 4) granted conditional authorization for Drugmaker Merck's COVID-19 pill, molnupiravir, the first pill shown to successfully treat COVID-19. It reduced hospitalizations, and deaths by around 50% in people severely infected with the coronavirus, according to interim clinical trial results announced on October 1. Due to the strong positive results, the Phase 3 trial is being stopped early at the recommendation of an independent group of medical advisers.
17 Mar 2021
As the world continues to battle the effects of the coronavirus pandemic, health experts and several pharmaceutical companies have come up with vaccines to reduce the effects. Oxford-AstraZeneca vaccine has given a significant boost to the global fight and here are five key things to know about the controversial vaccine.